Fresh Tracks Therapeutics Inc (NASDAQ:FRTX)
| 1.64 Delayed Data As of 12:50pm ET |  -0.025 / -1.51%Today’s Change | 1.51 Today|||52-Week Range 18.95 | -84.13% Year-to-Date |
Latest FRTX News | Press Releases
No recent news for Fresh Tracks Therapeutics Inc.
Today’s Trading
| Previous close | 1.66 |
| Today’s open | 1.56 |
| Day’s range | 1.51 - 1.64 |
| Volume | 1,538 |
| Average volume (3 months) | 137,143 |
| Market cap | $5.6M |
Data as of 12:50pm ET, 12/08/2022
Growth & Valuation
| Earnings growth (last year) | +42.39% |
| Earnings growth (this year) | +67.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -77.83% |
| P/E ratio | NM |
| Price/Sales | 45.51 |
| Price/Book | 0.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNOASonoma Pharmaceutica... | -0.16 | -9.41% |
| ---- | ||
| ---- | ||
| --Orphazyme A/S | 0.00 | 0.00% |
Data as of 1:38pm ET, 12/08/2022
Financials
| Next reporting date | March 22, 2023 |
| EPS forecast (this quarter) | -$1.25 |
| Annual revenue (last year) | $404.0K |
| Annual profit (last year) | -$39.5M |
| Net profit margin | -9,770.79% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
